Bipartisan group of senators calls for ways to improve 340B drug discount program

A bi­par­ti­san group of US sen­a­tors has re­leased a con­gres­sion­al call to the pub­lic for ideas and pol­i­cy so­lu­tions on how to im­prove the 340B pro­gram as phar­ma com­pa­nies con­tin­ue to put new re­stric­tions on their par­tic­i­pa­tion in it, and in­dus­try groups say they want to mod­ern­ize it.

Es­tab­lished in 1992, 340B is a fed­er­al health pro­gram that re­quires phar­ma com­pa­nies to of­fer dis­counts on their drugs to hos­pi­tals and oth­er health cen­ters that treat low-in­come pa­tients.

To read Endpoints News become a free subscriber

Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters

SIGN UP LOG IN